Ethics: Fostering Ethical Reflection on Financial Conflicts of Interest in Clinical Practice

2001 ◽  
Vol 11 (3) ◽  
pp. 9-13
Author(s):  
Brooke Hallowell
Keyword(s):  
Clinical Practice ◽  
Conflicts Of Interest ◽  
Ethical Reflection ◽  
Financial Conflicts Of Interest

scholarly journals Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines

PLoS ONE ◽  
2017 ◽  
Vol 12 (8) ◽  
pp. e0182856 ◽  
Author(s):  
Yidan Lu ◽  
Derek J. Jones ◽  
Nour Sharara ◽  
Tonya Kaltenbach ◽  
Loren Laine ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Conflicts Of Interest ◽  
Financial Conflicts Of Interest

Sa1014 – Prevalence and Relevance of Financial Conflicts of Interest Among Clinical Practice Guidelines in Nutrition

2019 ◽  
Vol 156 (6) ◽  
pp. S-254-S-255
Author(s):  
Alexa Sasson ◽  
Rishad Khan ◽  
Michael A. Scaffidi ◽  
Rishi Bansal ◽  
Jeevan Dhillon ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Conflicts Of Interest ◽  
Financial Conflicts Of Interest

Author Financial Conflicts of Interest, Industry Funding, and Clinical Practice Guidelines for Anticancer Drugs

2015 ◽  
Vol 33 (1) ◽  
pp. 100-106 ◽  
Author(s):  
Ariadna Tibau ◽  
Philippe L. Bedard ◽  
Amirrtha Srikanthan ◽  
Josee-Lyne Ethier ◽  
Francisco E. Vera-Badillo ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Conflicts Of Interest ◽  
Guideline Development ◽  
Industry Funding ◽  
Funding Sources ◽  
Consensus Statements ◽  
Financial Conflicts Of Interest ◽  
Based Medicine

Purpose Clinical practice guidelines (CPGs) and consensus statements (CSs) are used to apply evidence-based medicine or expert recommendations to clinical practice. Here we explore author financial conflicts of interest (FCOIs), sources of guideline funding, and their relationship with endorsement of specific drugs. Methods An electronic search of MEDLINE was conducted to identify CPGs and CSs for common solid cancers published between January 2003 and October 2013. The search was restricted to articles evaluating systemic therapy. We extracted data on self-reported author FCOIs, funding sources, use of manuscript writers, and endorsement of specific drugs in the abstract of the article. Results Of 142 articles evaluated, 64% were CPGs, and 36% were CSs. The proportion of articles reporting FCOIs improved from 11% in 2003 to 93% in 2013 (P for trend < .001). Only 45% of articles explicitly reported funding sources. Of these, 65% disclosed partial or full industry sponsorship. Use of manuscript writers was declared in 13%, but many articles did not explicitly report the role of authors in the writing of the manuscript. Endorsement of specific drugs was significantly associated with author FCOIs (odds ratio [OR], 7.29; P = .001), but not with industry funding (OR, 0.95; P = .37). Conclusion Reporting of FCOIs in CPGs and CSs has improved over time. Despite prevalent funding of guideline development by industry, such funding is not associated with endorsement of specific drugs. Author FCOIs are prevalent, and endorsement of a specific drug seems to be more common when authors have FCOIs with the pharmaceutical company marketing that drug.

Sign in / Sign up

Export Citation Format

Share Document